Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitazoxanide vs Metronidazole in C. difficile Colitis
NCT00417872Phase 2Completed
- Sponsor
- Romark Laboratories
- Start
- Jan 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nitazoxanide in Clostridioides difficile infection (CDI), sponsored by Romark Laboratories. Started Jan 2004; status: completed.
02
Drugs
nitazoxanide
03
Conditions
Clostridioides difficile infection (CDI)
Beyond the preview
Go deeper on NCT00417872.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00417872.